Deucravacitinib Shows Joint, Skin Symptom Improvements in Psoriatic Arthritis
Drug Topics
JUNE 11, 2025
The study cohort included 670 patients who were diagnosed with PsA of at least a 3 month duration and have active plaque psoriatic skin lesions or a documented medical history of plaque psoriasis. READ MORE: Significant Knowledge Gap Exists in Patient Awareness of Psoriatic Disease The study found that 54.2%
Let's personalize your content